Quality Associate, QA Operations

About Us…

Obsidian Therapeutics is pioneering engineered cell and gene therapies to deliver transformative outcomes for patients. Obsidian’s programs apply our cytoDRiVE® technology in Cell and Gene therapy products to control expression of proteins for enhanced therapeutic efficacy and safety. Obsidian’s lead program is currently in clinical development for the treatment of patients with metastatic melanoma and non‑small cell lung cancer.

Obsidian Therapeutics is pioneering engineered cell and gene therapies to deliver transformative outcomes for patients. Obsidian’s programs apply our cytoDRiVE® technology in Cell and Gene therapy products to control expression of proteins for enhanced therapeutic efficacy and safety. Obsidian’s lead program is currently in clinical development for the treatment of patients with metastatic melanoma and non‑small cell lung cancer. We’re proud of our diverse talented team and committed to cultivating an environment of inclusion where each person feels a strong sense of belonging and is supported to continuously learn and contribute their best work.

Our Research team is based in the heart of Cambridge, MA, and Technical Operations team is based in our purpose built facility in Bedford, MA. Obsidianites enjoy a highly collaborative culture, competitive salary and benefits, and potential for ownership through stock options.

We’re growing our team to support the advancement of our clinical studies, and seeking a motivated, purpose‑driven individual for a Quality Associate, Quality Assurance Operations position. As a member of the Quality Assurance organization, this role provides QA support of CDMO drug product manufacturing, as well as other critical materials used in GMP‑regulated environments to ensure compliance with applicable regulatory requirements, deliver for our patients, and achieve company goals.

You’ll be a vital part of a highly collaborative team working to achieve Obsidian’s vision by translating innovative science into medical breakthroughs for patients starting with our lead program OBX-115, a novel engineered tumor‑infiltrating lymphocyte (TIL) therapy.

This is a unique opportunity to be a contributor in a well‑funded clinical company with blue chip investors, field‑leading advisors, best‑in‑class partners, and an experienced team. You'll help us build a dynamic, innovative, passionate, collaborative, and successful organization focused on delivering transformative therapies in areas of greatest clinical need.

• Support QA Operations CDMO point person to ensure CDMO adherence to Good Manufacturing Practices (GMP), applicable regulations, and Obsidian Therapeutics policies.
• Serve as a point of coordination for QA support across manufacturing operations by partnering with CMC, QA Operations, and Supply Chain/materials management teams to review documentation, resolve quality-related questions, and support timely execution of GMP activities.
• Review batch data (e.g., batch records, deviations, in‑process data, EM data, QC release testing, and other quality systems as applicable) and elevate issues as needed to support product disposition decisions.
• Maintain and archive batch records and other disposition supporting documents in internal document/record repositories, ensuring completeness, accuracy and audit readiness.
• Provide timely QA support for change controls, GMP investigations, associated CAPAs, and effectiveness checks by reviewing records, supporting impact assessments, tracking action items, and helping ensure quality system activities are completed accurately and within required timelines.
• Participate in IND preparedness and inspection readiness activities and provide QA support during regulatory site inspections, including follow up activities.
• Contribute to process improvement initiatives, including gap analysis and risk communication.
• Support Supplier Quality Agreement review activities by identifying needed updates, clarifications, and follow‑up actions and coordinating input from relevant internal stakeholders.
• Estimated travel:…